血液肿瘤表观遗传调控及其靶向治疗研究进展

Research advances in epigenetic regulation and targeted therapy of hematological tumors

  • 摘要: 血液肿瘤亦称恶性血液病,包括急/慢性白血病、淋巴瘤、多发性骨髓瘤以及骨髓增殖性疾病等,是严重威胁人类生命健康的恶性疾病。近年来,随着表观遗传学在医学研究中的兴起,很多学者通过对表观遗传学作用机制的深入探究发现血液肿瘤的新治疗靶点,并研发出相应的药物,揭示了表观遗传修饰机制的紊乱,或将成为血液肿瘤临床诊断、靶向治疗与预后评估的新方向。本文就表观遗传调控与血液肿瘤的关系、表观遗传学靶向治疗在恶性血液病中的研究进展予以综述。

     

    Abstract: Hematological tumors,also known as neoplastic diseases of blood,include acute/chronic leukemia,lymphoma,multiple myeloma,and myeloproliferative diseases.They are malignant diseases that seriously threaten human health.In recent years,as epigenetics has become one of the research hotspots in medicine,many scholars have discovered new therapeutic targets for hematological tumors through exploring the epigenetics mechanism and developed corresponding drugs.It reveals that the alteration in epigenetic modification will become a new direction for clinical diagnosis,targeted therapy and prognosis evaluation of hematological tumors.This article reviews the research advances in relationship between epigenetic regulation and hematological tumors,and the application of epigenetic targeted therapy in hematologic malignancies.

     

/

返回文章
返回